# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JMP Securities analyst Jason Butler maintains Precigen (NASDAQ:PGEN) with a Market Outperform and lowers the price target fr...
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Precigen (NASDAQ:PGEN) with a Buy and lowers the price targ...
Precigen (NASDAQ:PGEN) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.10) by...